Moderna stock surges 17% on coronavirus vaccine trial news – MarketWatch

0
37
Moderna stock surges 17% on coronavirus vaccine trial news – MarketWatch

New study shows ‘robust’ immune response to trial vaccine, Moderna says
Read More

LEAVE A REPLY

Please enter your comment!
Please enter your name here